SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001595585-21-000040
Filing Date
2021-02-22
Accepted
2021-02-22 16:40:08
Documents
15
Period of Report
2021-02-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcda-20210216.htm   iXBRL 8-K 37053
7 GRAPHIC tcda-20210216_g1.jpg GRAPHIC 5018
  Complete submission text file 0001595585-21-000040.txt   196584

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcda-20210216.xsd EX-101.SCH 2433
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcda-20210216_cal.xml EX-101.CAL 720
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcda-20210216_def.xml EX-101.DEF 1657
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcda-20210216_lab.xml EX-101.LAB 25293
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcda-20210216_pre.xml EX-101.PRE 13200
8 EXTRACTED XBRL INSTANCE DOCUMENT tcda-20210216_htm.xml XML 11265
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Filer) CIK: 0001595585 (see all company filings)

IRS No.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38558 | Film No.: 21660906
SIC: 2834 Pharmaceutical Preparations